Generation of obese rat model by transcription activator-like effector nucleases targeting the leptin receptor gene by Chen, Yuting et al.
SCIENCE CHINA 
Life Sciences 
© Science China Press and Springer-Verlag Berlin Heidelberg 2016  life.scichina.com   link.springer.com 
                  
†Contributed equally to this work 
*Corresponding author (email: myliu@bio.ecnu.edu.cn)  
**Corresponding author (email: dlli@bio.ecnu.edu.cn) 
THEMATIC ISSUE: Signaling and regulatory biology February 2017  Vol.60  No.2: 152–157 
• RESEARCH PAPER • doi: 10.1007/s11427-016-5049-y 
Generation of obese rat model by transcription activator-like 
effector nucleases targeting the leptin receptor gene 
Yuting Chen1†, Wenqing Lu1†, Na Gao1†, Yi Long1, Yanjiao Shao1, Meizhen Liu1, 
Huaqing Chen1, Shixin Ye2, Xueyun Ma1, Mingyao Liu1,3* & Dali Li1** 
1Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, 
Shanghai 200241, China; 
2Ecole Normale Supérieure, Institut de Biologie de l’ Ecole Normale Supérieure, Institut National de la Santé et de la Recherche Médicale 
U1024, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8197, Paris F-75005, France; 
3Institute of Biosciences and Technology, Department of Molecular and Cellular Medicine, Texas A&M University Health Science Center, 
Houston, Texas 77030, USA 
Received September 12, accepted November 6, 2015; published online May 25, 2016 
 
The laboratory rat is a valuable mammalian model organism for basic research and drug discovery. Here we demonstrate an 
efficient methodology by applying transcription activator-like effector nucleases (TALENs) technology to generate Leptin re-
ceptor (Lepr) knockout rats on the Sprague Dawley (SD) genetic background. Through direct injection of in vitro transcribed 
mRNA of TALEN pairs into SD rat zygotes, somatic mutations were induced in two of three resulting pups. One of the found-
ers carrying bi-allelic mutation exhibited early onset of obesity and infertility. The other founder carried a chimeric mutation 
which was efficiently transmitted to the progenies. Through phenotyping of the resulting three lines of rats bearing distinct 
mutations in the Lepr locus, we found that the strains with a frame-shifted or premature stop codon mutation led to obesity and 
metabolic disorders. However, no obvious defect was observed in a strain with an in-frame 57 bp deletion in the extracellular 
domain of Lepr. This suggests the deleted amino acids do not significantly affect Lepr structure and function. This is the first 
report of generating the Lepr mutant obese rat model in SD strain through a reverse genetic approach. This suggests that 
TALEN is an efficient and powerful gene editing technology for the generation of disease models. 
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Leptin receptor (Lepr) belongs to the super family of cyto-
kine receptors which play key roles in maintaining body 
weight. It is a single-transmembrane domain protein with 
several alternatively spliced isoforms that are distributed in 
many types of tissues (Kielar et al., 1998; Tartaglia et al., 
1995). Lepr deficiency is associated with obesity and obe-
sity-related diseases such as diabetes (Rosmond et al., 
2000). The db/db mouse strain carrying a point mutation 
leading to premature termination of the Lepr gene has been 
widely used as a model for obesity, diabetes and metabolic 
syndrome (Chen et al., 1996). The Zucker fatty rat (ZFR) 
strain also contains a Gln269Pro substitution in Lepr 
(Phillips et al., 1996) and the Koletsky rat (f) strain contains 
a T2349A transversion resulting in a Tyr763Stop nonsense 
mutation in Lepr just before the transmembrane domain 
(Wu-Peng et al., 1997). Because having an identical genetic 
background is critical for animal models in both basic sci-
entific studies and innovative drug discovery, we sought to 
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generate Lepr mutant rat strains through a reverse genetic 
approach.  
Site-specific genetically modified rats have been gener-
ated by our group using zinc finger nucleases (ZFNs) 
(Geurts et al., 2009), gene-targeting in embryonic stem cells 
(Tong et al., 2010), transcription activator-like effector nu-
cleases (TALENs) (Tesson et al., 2011), and most recently 
by the clustered regularly interspaced short palindromic 
repeats/Cas9 (CRISPR/Cas9) system (Li et al., 2013). 
Among the available technologies, although embryonic 
stem cell based gene targeting shows the best accuracy per-
formance, it is a time- and labor-consuming strategy de-
manding great expense and experienced scientists, and it 
usually yields a low germline transmission efficiency (Tong 
et al., 2011). Through direct injection of ZFN pairs into 
one-cell embryos, a gene modified rat can be generated. 
However, optimization of zinc-finger modular arrays is also 
costly and off-target digestion is also reported (Urnov et al., 
2010). Previously, we have shown that the CRISPR/Cas9 
system is a powerful and highly efficient technology with 
less than ten days of hands-on working time (Shao et al., 
2014). However, off-targeting excision induced a relatively 
high frequency of undesired mutations that are a major ad-
verse effect (Pattanayak et al., 2013). The DNA binding 
domain of TALENs is derived from transcription activa-
tor-like effector (TALE) proteins which were originally 
discovered from the plant pathogenic bacteria Xanthomonas 
(Moscou and Bogdanove, 2009). TALEs possess a different 
single 34 aa module distinct from zinc finger motifs that 
recognizes the corresponding single target nucleotides hav-
ing more predictable DNA-binding rules (Boch et al., 
2009). Tesson and colleagues have reported the first estab-
lishment of a targeted-knockout rat by TALENs (Tesson et 
al., 2011). We have recently demonstrated that the TALENs 
are an effective genetic tool for rapid gene disruption with 
high efficiency and heritability in the mouse with distinct 
genetic background (Qiu et al., 2013).  
Here we demonstrate the feasibility of generating Lepr 
KO rats via TALEN-mediated gene disruption. We suc-
cessfully generated genetically modified Lepr rats in a SD 
genetic background that exhibited a high efficiency of 
germline transmission. We observed both a bi-allele mutant 
founder and three homozygous Lepr KO rat lines with dis-
tinct genomic mutations.  
RESULTS AND DISCUSSION  
Design of TAL modules and rat Lepr locus targeting 
in vivo  
According to the rat Lepr nucleic acid sequence obtained 
from the NCBI (National Center for Biotechnology Infor-
mation) genbank database, we designed a pair of TALE 
modular arrays targeting two adjacent sites with an 18 bp 
interval (spacer) on exon 2 of the rat Lepr gene. The TALE 
arrays were fused to the N terminus of the catalytic domain 
of Fok I nuclease. In vitro transcribed mRNA of the 
TALEN pair was injected into 153 rat one-cell embryos and 
this resulted in 3 F0 newborns. Using the T7 endonuclease I 
(T7EI) digestion assay, we identified two F0 pups that were 
founders containing mutations in the Lepr locus. Interest-
ingly, founder 2 rat carried a bi-allelic mutation and no 
wild-type PCR band was identified (Figure 1A). To deter-
mine the exact mutation sequence, PCR products were TA 
cloned and at least ten colonies were sequenced. All muta-
tions of Lepr were identified and listed in Figure 1A. In 
summary, founder 1 had two mutants: a non-frame-shifting 
57 bp deletion and an 18 bp insertion which generated a 
TGA premature stop codon. Since all ten TA clones from 
founder 2 rat exhibited a 394 bp deletion in the Lepr locus, 
this suggested that the founder was homozygous (Figure 
1B). It was confirmed that founder 2 rat exhibited an obese 
phenotype by 18 weeks of age (Figure 1C). The mutation 
rate was high, as was previously reported (Tesson et al., 
2011), supporting our studies in mouse embryos that the 
optimal spacer length is about 15–19 bp (Qiu et al., 2013).  
Highly efficient germline transmission of 
TALEN-induced Lepr mutations 
Successful germ-line transmission is important for the es-
tablishment of knockout rat lines. Two founders were sepa-
rately backcrossed with WT SD rats to determine the 
germline transmission efficiency. Indeed, founder 2 rat 
showed infertility, further suggesting that it was homozy-
gous. The germline transmission rate of founder 1 rat 
reached 100% as detected by the T7E1 assay (Figure 1D). 
To determine the mutations generated in individual found-
ers, PCR products were sequenced (Figure 1E). In addititon 
to two mutant alleles being identified in the founder, a pre-
viously undetected allele with 1 bp deletion was also deter-
mined in the F1 pups. This suggests an incomplete sequenc-
ing of the TA clones or an uneven distribution of certain 
mutation-bearing cells between the toes and germ cells 
(Figure 1E). These results indicate that TALEN-induced 
gene mutation is highly heritable in rats.  
Characterization of the phenotypes of Lepr mutant rat 
Three strains of rats containing different Lepr mutations 
were generated separately by intercrossing between the F1 
generations with the same mutation. We named them 
Leprᇞ57/ᇞ57 rat (deletion 57 bp), Leprᇞ1/ᇞ1 rat (deletion 1 bp) 
and Leprin18/in18 rat (insertion 18 bp). The non-frame-shifting 
57 bp deletion resulted in a 19 amino acid deletion in the 
extracellular domain of Lepr in Leprᇞ57/ᇞ57 rats. The 
Leprᇞ1/ᇞ1 strain contained a frame-shifting 1 bp deletion 
which disrupted gene function. An 18 bp random sequence 
containing a TGA stop codon was inserted into the Lepr 
locus in Leprin18/in18 strain which lead to premature termina-
tion of transcription. The earliest onset of obesity was ob-
served at 5–6 weeks in Leprᇞ1/ᇞ1 and Leprin18/in18 rats, but 
not in Leprᇞ57/ᇞ57rats. This indicated that the corresponding 
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Figure 1  TALEN-induced mutations of Lepr in rat with efficient germline transmission. A, Detection of mutations in F0 rats generated by injection of 
TALEN mRNA targeting Lepr using T7 endonuclease assay. PCR primers were designed flanking the TALEN binding sites of Lepr. PCR products (WT, 
871 bp) were melted, and annealed with a similar amount of PCR products amplified from wild-type mouse genomic DNA to form heteroduplex DNA. The 
DNA heteroduplex was then subjected to mismatch sensitive endonuclease (T7E1) assays and the products were resolved in 1.5% agarose gels. Black arrow 
indicates wild-type rat, Green arrow indicates rat bearing mutations, red arrow indicates rat bearing bi-allelic mutation. M, DNA marker. B, Frequencies and 
sequences of TALEN-induced mutations in SD rats. The binding sites of the TALEN half-site are shown in blue and underlined. A dash represents a single 
base deletion. Insertions or substitutions are indicated in red letters. The length and frequency of indels are labeled to the right of each sequence. C, 
18-week-old Lepr founder 2 (right) and its wild-type littermate (left) were anesthetized and photographed. D, Identification of F1 of Lepr founder 1 using T7 
endonuclease assay. PCR primers were designed flanking the TALEN binding sites of Lepr. PCR products (871 bp) were melted, and annealed with a similar 
amount of PCR products amplified from wild-type mouse genomic DNA to form heteroduplex DNA. The DNA heteroduplex was then subjected to mis-
match sensitive endonuclease (T7E1) assays and the products were resolved in 1.5% agarose gels. Underlined data indicated rat bearing mutations. M, DNA 
marker. E, Sequences of TALEN-induced mutations in F1 of Lepr founder 1. The binding sites of the TALEN half-site are shown in blue and underlined. A 
dash represents a single base deletion. Insertions or substitutions are indicated by red letters and underlining. Allele that appeared in F1 but was not originally 
identified in the founder is highlighted in yellow. The number of F1 rats with each genotype is listed on the right. #1, 3, 4, 8, 15, 18, 19, 20 of F1 rats shown 
in (D) containing 57 bp deletion; #2, 5, 6, 7, 10, 11, 12, 13, 16, 17, 21, 22, 23, 24 of F1 rats containing 18 bp insertion; #9,14 of F1 rats containing 1 bp dele-
tion. 
19 amino acids in the extracellular domain of Lepr were not 
indispensable for its function. Firstly, we detected the rela-
tive expression of Lepr in different tissues of Leprin18/in18 and 
wild type littermates. We found that the expression of Lepr 
was significantly lower than that of wild type littermates 
with regard to brain, abdominal adipose, kidney, and small 
intestine (Figure 2A). This suggests that the premature stop 
codon of Lepr significantly reduced its mRNA stability in 
Leprin18/in18 rat, as it is well known that nonsense mutation 
induces mRNA decay (Hentze and Kulozik, 1999). Next, 
the body weight of Leprin18/in18 and WT male rats were de-
termined at 13 weeks of age (Figure 2B, Left). Leprin18/in18 
rats were significantly heavier than wild type littermates 
(603.8 g, SE=7.77 vs. 366.5 g, SE=12.32, P<0.0001). In the 
glucose tolerance test (IPGTT), Leprin18/in18 rats showed that 
the blood glucose levels were significantly higher than those 
of wild type littermates at all tested time points (Figure 2B, 
Middle). Using the insulin tolerance test (ITTs), Leprin18/in18 
rats showed decreased sensitivity to injection of insulin than 
did wild type littermates, indicating resistance to insulin 
treatment (Figure 2B, Right). These data indicated that glu-
cose homeostasis of Leprin18/in18 rats were severely impaired. 
Moreover, examination of abdominal fat (ABT) from 
Leprin18/in18 rats revealed a considerable cellular hypertrophy 
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Figure 2  Phenotypes of Leprin18/in18 rats. A, Relative mRNA level of Lepr in variant tissues of Leprin18/in18 and wild type littermates. ***, P<0.001 by 
two-tailed t-test. B, Left, Body weight of 13-week-old Leprin18/in18 rats and its wild-type littermate. Middle, Leprin18/in18 and its wild-type littermates were 
fasted overnight 16 h, intraperitoneal injection with glucose (2 g kg1 body weight) and whole-blood glucose levels were monitored 2 h. Single Asterisks 
indicate significant diﬀerences (P<0.05), double Asterisks indicate P<0.01, and triple Asterisks indicate P<0.001 between lean and obese rats, the same 
below. Right, Leprin18/in18 and its wild-type littermates were fasted for up to 4 h, and intraperitoneal injection with insulin (1.5 U kg1) and whole-blood glu-
cose levels were monitored 2 h. C, Left, Comparison of H&E-stained abdominal adipose of Leprin18/in18 (lower) and its wild-type littermate (upper). Dramatic 
cellular hypertrophy is observed in abdominal fat. Scale bars: 100 μm. Right, Oil-Red-O staining of liver sections shows marked increase of lipid accumula-
tion in Leprin18/in18 rats (lower) relative to its wild-type littermates (upper). KO indicates the Leprin18/in18 rats, WT indicates wild-type littermates, A, B and C 
n=5 per group. 
compared to wild type littermates (Figure 2C, Left). Fur-
ther, Oil-Red-O staining of frozen sections from Leprin18/in18 
rat livers showed strong signals indicating lipids, while the 
counterpart sections from the littermate controls were barely 
stained (Figure 2C, Right). These data indicate that 
Leprin18/in18 rats showed a marked increase of lipid accumu-
lation in the liver. We also compared the serum biochemical 
indexes of Leprin18/in18 rats with wild type littermates. The 
Leprin18/in18 rats displayed significantly higher levels of tri-
glyceride, total cholesterol, LDL-cholesterol, AST/ALT 
(Table 1). The Leprᇞ1/ᇞ1 rats showed a similar phenotype as 
Leprin18/in18 rats (data not shown). In conclusion, these re-
sults suggested that our Lepr KO rat in a pure SD genetic 
background generated by TALENs is a valuable animal 
model for obesity and obesity-related disease research. 
In this article, we successfully generated Lepr KO rats by 
TALENs by targeting exon 2 of the Lepr gene in a pure SD 
genetic background. We observed a robust phenotype of 
Lepr-deficient rats. The Leprᇞ1/ᇞ1 and Leprin18/in18 rats with a 
single background developed obesity and obesity-related 
features, such as hyperlipemia, insulin-resistance, and hy-
pertriglyceridemia, in the same manner as Zucker fatty rats. 
Since it is in a pure genetic background which will be better 
for basic scientific research and drug development than 
Zucker rats with mixed genetic background, our TALEN- 
generated model rat strains possess distinct advantages for 
obesity research. 
MATERIALS AND METHODS 
TALEN expression vector construction  
We identified target sites of the Lepr using the online soft-
ware (http://boglabx.plp.iastate.edu/TALENT/help.php) (Cer- 
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Table 1  Blood metabolic parameters of the WT and Leprin18/in18 rats at 13 weeks of agea) 
Indices WT Leprin18/in18 rats P 
Triglyceride (mmol L1) 0.608±0.081 1.795±0.128 0.0002 
Total cholesterol (mmol L1) 0.745±0.025 1.653±0.118 0.0003 
LDL-cholesterol (mmol L1) <0.26 0.340±0.027 
HDL-cholesterol (mmol L1) 0.505±0.017 0.535±0.037 0.4881 
AST (U L1) 50.750±2.869 73.500±3.797 0.0031 
ALT (U L1) 26.250±2.175 40.500±2.327 0.0042 
AST/ALT 1.955±0.101 2.356±0.0397 0.0103 
a) LDL, Low density lipoprotein. HDL, High density lipoprotein. AST, aspartate aminotransferase. ALT, alanine aminotransferase. Analytes were meas-
ured in serum and these data were tested in ADICON Clinical Laboratories. Data are given as means±SEM for surviving animals (n=5 for WT and 
Leprin18/in18 rats, respectively). 
mak et al., 2011). Nucleotide-recognizing TALE single-unit 
vectors and TALEN expression vectors were obtained from 
Bo Zhang (Peking University). We constructed TALE re-
peat arrays and TALE nuclease expression vectors accord-
ing to the methods as described (Huang et al., 2011).  
Preparation of TALEN-coding mRNA in vitro 
To prepare mRNA for microinjection, we linearized the 
TALEN expression vector by Not I restriction enzyme di-
gestion, followed by phenol/chloroform extraction and eth-
anol precipitation. Then, following the manufacturer’s in-
structions, the linearized DNA was transcribed using Sp6 
mMESSAGE mMACHINE Kit (Ambion, USA). We re-
covered mRNA by lithium chloride precipitation and resus-
pended mRNA in nuclease-free water. 
Microinjection of one-cell zygotes 
Superovulation of SD rat females (SLAC Shanghai) was 
obtained by mating with males of the same strain. One-cell 
stage embryos were obtained from the ampulla oviducts of 
the superovulated females. The embryos were washed and 
incubated in KSOM embryo culture medium (Millipore, 
USA) for 3–4 h at 37°C, 5% CO2 before injection. The 
mRNA of TALEN pairs at a concentration of 20 ng μL1 
was injected into the cytoplasm of one-cell stage embryos 
using an Eppendorf TransferMan NK2 micromanipulator. 
Injected zygotes were transferred into pseudopregnant fe-
male rats immediately after injection. The rats were housed 
in standard cages in a specific pathogen-free facility on a 12 
h light/dark cycle with ad libitum access to food and water. 
All animal experiments conformed to the regulations draft-
ed by the Association for Assessment and Accreditation of 
Laboratory Animal Care in Shanghai and were approved by 
the East China Normal University Center for Animal Re-
search. 
Genotyping  
Genomic DNA was extracted from rat toes or tail clips ac-
cording to a standard DNA extraction procedure. PCR was 
performed with the following primers (Lepr-F: 5′-GAGA- 
GCCTATGGGGTATTTCCTA-3′, Lepr-R: 5′-TACTTAC- 
CTAGTTGGCGGAAAAC-3′). The PCR products were 
re-annealed to enable heteroduplex formation and then di-
gested with T7 endonuclease I (New England Biotech, UK) 
in a 10 L reaction volume at 60 ng L1 concentration for 
30 min at 45C. The mixture was then redissolved and ana-
lyzed on a 1.5% agarose gel. The exact sequences of found-
ers were determined by DNA sequencing. PCR products 
were cloned using a TA cloning kit (TaKaRa, Japan) fol-
lowing the manufacturer’s instructions. At least 10 colonies 
were picked from each transformation and then sequenced 
with RV-M primer.   
Total RNA extraction and Q-PCR 
The rats were sacrificed and indicated tissues were dissected 
for total RNA extraction with RNAiso Plus (TaKaRa) kit. 
Primer pair for qRT-PCR detection of rat Lepr was synthe-
sized, Lepr-RT-F: 5′-TGCTTGTTGTGAAGCCCGAT-3′, 
Lepr- RT-R: 5′-CGCTGTCTACCAGCAGAGAT-3′. qRT- 
PCR was performed with SYBR Green (TaKaRa). 
Glucose tolerance tests (IPGTTs) 
After overnight 16 h fasting, the rats were weighed and in-
jected intraperitoneally with glucose (2 g kg1 body weight). 
Blood samples were collected from the tip of the tail imme-
diately prior to and 15, 30, 45, 60, 90 and 120 min after 
injection. Blood glucose levels were measured at each time 
point using an ACCU-CHEK® Performa Nano (Roche, 
Switzerland). 
Insulin tolerance tests (ITTs) 
The rats were fasted for up to 4 h, after which they were 
weighed and intraperitoneally injected with insulin (1.5 U 
kg1). Blood samples were collected from the tip of the 
tail prior to and 15, 30, 45, 60, 90 and 120 min after injec-
tion. Blood glucose levels were measured at each time point 
using an ACCU-CHEK® Performa Nano. 
Oil-Red-O staining 
The livers of rats were fixed and frozen. 5 μm liver frozen 
sections were sliced from the frozen tissues and rinsed in 
ddH2O. For staining, sections were placed in Oil-Red-O 
solution (0.5% Oil-Red-O in 60% isopropyl alcohol) for 
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10 min. Then sections were rinsed in 60% isopropyl alco-
hol for 30 s, followed with ddH2O, and counterstained in 
hematoxylin for 3 min. Finally, sections were rinsed under 
running water for 15 min and mounted with aqueous solu-
tion. 
Blood biochemical index determination 
After overnight fasting, the rats were bled from their eye 
sockets. Blood was stored at 4°C for 2 h and then centri-
fuged at 13400×g, 4°C, for 5 min. Biochemical parameters 
of the rat serum were measured in ADICON Clinical La-
boratories (INC, Shanghai). 
Statistical analysis 
The results are presented as means±SEM. Statistical analy-
sis was performed by a Mann-Whitney test using GraphPad 
Prism 5 software (GraphPad Software, USA). P<0.05 is 
considered statistically significant. 
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